Roche to acquire 89bio, and its phase 3 FGF21 analog for the therapy of moderate to severe MASH for US $3.5 billion
On Sept. 17, 2025, Roche announced that it has entered into a definitive merger agreement to acquire 89bio,…
On Sept. 17, 2025, Roche announced that it has entered into a definitive merger agreement to acquire 89bio,…
On Sept. 17, 2025, GSK announced plans to invest $30 billion across the United States in research and…
On Sept. 10, 2025, Merck announced it was scrapping research operations in London, citing the UK’s challenging business…
On Sept. 4, 2025, a global collaboration that includes experts at the Wellcome Sanger Institute announced mapping out…
On Aug. 4, 2025, UK Biobank announced it had reached a historic milestone – completing 100,000 whole-body imaging…
On Jul. 9, 2025, a research team led by Eske Willerslev, professor at the University of Copenhagen and…
On Jul. 1, 2025, an international team of researchers led by by the Université de Poitiers and Cardiff…
On Jun. 26, 2025, a team of UK-based scientists announced they are developing technology to create the first…
On Jun. 16, 2025, the National Institute for Health and Care Excellence (NICE) announced that the recommendation in…
On Jun. 13, 2025, people in England will become the first in the world to receive belantamab mafodotin…
On May 21, 2025, A research programme by the UK Health Security Agency (UKHSA) and the Animal and Plant…
On May 15, 2025, researchers at the Translational Genomics Research Institute (TGen), part of City of Hope, announced…
On May 8, 2025, A strain of bacterium that often causes infections in hospital can break down plastic,…
On Apr. 23, 2025, researchers from the Wellcome Sanger Institute, University of California San Diego and their collaborators…
On Apr. 21, 2025, LifeScienceHistory.com published the cartoon: “The National Institutes of Health (NIH) and U.S. Healthcare in…
On Apr. 15, 2025, Moderna announced that its manufacturing facility in Harwell, Oxfordshire, the Moderna Innovation and Technology…
On Apr. 11, 2025, the UK National Institute for Health and Care Excellence (NICE) recommended capivasertib (also called…
On Mar. 25. 2025, the UK Health Security Agency (UKHSA) published its view on the pathogen families that…
On Jan. 21, 2025, Rice University announced that four research groups are part of an inaugural cohort of…
On Jan. 14, 2025, an international research team led by the University of Edinburgh reported new genetic risk…
On Jan. 13, 2025, scientists from the Francis Crick Institute, UCL, UCLH and Personalis announced they have found…
On Jan. 7, 2025, researchers at the Francis Crick Institute, MRC Harwell Institute and UCL Queen Square Institute…
On Nov. 28, 2024, scientists from King’s College London reported that an injection given during some asthma and…
On Nov. 27, 2024, a study led by the University College London reported that large language models, a…
On Nov. 9, 2024, the World Health Organization announced that three additional countries had confirmed travel-related cases of…
On Nov. 6, 2024, The United Kingdom’s Chief Veterinary Officers was urging all bird keepers to follow scrupulous…
On Nov. 1, 2024, researchers reported results from a study that show a low-sugar diet during pregnancy and…
On Oct. 9, 2024, the Nobel Foundation awarded the Nobel Prize in Chemistry: one half to David Baker,…
On Oct. 24, 2024, GSK announced an $800 million investment that will bring state-of-the-art drug substance manufacturing and…
On Aug. 22, 2024, the Medicines and Healthcare Products Regulatory Agency (MHRA) announced it had licensed the immunotherapy…